FIDIS™ Thyroid Panel
The BMD FIDIS™ Thyroid Panel utilises the Luminex® xMAP technology to simultaneously detect Thyroperoxidase (TPO) and anti-Thyroglobulin (aTG) autoantibodies in a patient sample with only one assay procedure. The FIDIS™ Thyroid Panel offers increased sensitivity and specificity with the benefits of multiplexing technology.
The FIDIS™ is now in routine use in Australia and New Zealand. The Thyroid Panel is demonstrating excellent results as shown in the RCPA QAP Immunology Program. Further data showing the excellent performance of the FIDIS™ Thyroid Panel can be obtained by contacting Diagnostic Solutions.
- Fully automated using the BMD CARIS™ front-end pipetting system
- Fast turnaround of results
- 30:30 incubation times
- <30 secs per sample reading time using the FIDIS™ Luminex® system
- Bi-directional LIS interface
- enabling only requested tests to be reported
- On-board Levey-Jennings QC monitoring
Other FIDIS™ Panels
BMD have extensive range of Autoimmune Panels now available using the FIDIS™ system. They include the following;
-
Connective 10 Panel: simultaneous detection and characterisation of dsDNA, Centromere and 8 ENA antibodies.
Learn more
-
Celiac IgA Panel: simultaneous detection of IgA antibodies to tTG and Gliadin.
Learn more
-
Celiac IgG Panel: simultaneous detection of IgG antibodies to tTG and Gliadin.
Learn more
-
Vasculitis Panel: simultaneous detection of antibodies to ANCA-MPO, ANCA-PR3 and GBM.
Learn more
-
Rheuma Panel: simultaneous detection of IgM antibodies to Human and Animal Rheumatoid Factor.
Learn more
-
Cytokine Panels: there are now a large range of human cytokine panels also available using the FIDIS™ System.
Learn More
Thyroid Quality Control (QC)
Diagnostic Solutions has QC material available for use by ELISA, Immunoassay or FIDIS™ methodologies. Learn more.
Back to TOP